» Download Public Reports
38 reports
- Industry report
- May 2013
- 22 pages
... Medicine: definition 2 The tailoring of medical treatment to the specific characteristics of each patient. [It] does not literally mean the creation of drugs or medical devices that are unique ...
January 2013
... Portfolio and recent developments is also provided in the report. Transparency market research liver diseases therapeutics market - global industry analysis, size, share, trends ...
July 2012
... Of obesity therapeutics and was a major participant in the recapitalization of orexigen (orex), an obesity therapeutics company, at $1.45 Per share in december 2011. He has developed deep relationships ...
May 2012
... Management discussion section operator: good afternoon ladies and gentlemen and welcome to cytori therapeutics' first quarter earnings conference. Before we begin, we want to advice you that over ...
May 2012
... Tomography) and in cancer therapy (radiation therapy). In both applications, radiation is used to improve the outcome of the patient. However radiation has to be applied wisely and carefully in order ...
March 2012
... A measuring instrument for use in radiation therapy treatment of cancer. The measuring device automatically and safely measures exactly how much and where the radiation therapy treatment should be applied ...
March 2012
... On disposal of bioassays business Following restructuring, iba equipment now operating as two segments, proton therapy / accelerators and dosimetry. Bioassays reclassified as Held for sale And excluded ...
March 2012
... Conversion rate of the existing backlog this quarter that is related to production planning and is not unusual for this type of activity. No new orders were signed in q1 for proton therapy projects ...
February 2012
... Not to commission the particle therapy facility at the university hospital schleswig-holstein in kiel. The reason given by the company is the unlikelihood that the project would make a profit. Particle therapy ...
January 2012
... For physiology or medicine. rnai therapeutics, such as "sirnas," require delivery technology to be effective systemically. Tekmira believes its lnp technology represents the most widely adopted delivery ...
» Purchase Premium Reports
(From $ 250 - $ 3 500)
About 3 400 reports
- $ 3 500
- Industry report
- April 2013
- by GBI Research
ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment Summary GBI Research, the leading business intelligence provider, has released its ...
April 2013
$ 3 270
Global Market Watch: The broad ?health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac ...
May 2013
$ 2 500
Pain - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Pain - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on ...
April 2013
$ 2 500
Cancer Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Cancer Pain Global Clinical Trials Review, H1, 2013" provides data on the Cancer Pain clinical trial scenario. ...
April 2013
$ 2 500
Osteoarthritis Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Osteoarthritis Pain Global Clinical Trials Review, H1, 2013" provides data on the Osteoarthritis ...
May 2013
$ 2 000
Staphylococcus Aureus Infections - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Staphylococcus Aureus Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
May 2013
$ 2 000
Dental Pain - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Dental Pain - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
